Skip to main content
INSMED Inc logo

INSMED Inc — Investor Relations & Filings

Ticker · INSM ISIN · US4576693075 LEI · 529900Q55QAG41CCAC11 US Manufacturing
Open in API
Filings indexed 1,323 across all filing types
Latest filing 2013-05-28 Director's Dealing
Country US United States of America
Listing US INSM

About INSMED Inc

https://insmed.com/

Insmed Incorporated is a global biopharmaceutical company dedicated to developing and commercializing therapies for patients with serious and rare diseases. The company's primary focus is on addressing areas of high unmet medical need. Its marketed product, Arikayce (liposomal amikacin for inhalation), is a treatment for Mycobacterium avium complex (MAC) lung disease. Insmed leverages proprietary technologies, such as its advanced liposomal pulmonary delivery system, to create novel treatments. The company maintains a diverse pipeline of investigational medicines and is actively advancing potential new therapies through various stages of clinical trials.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2013-05-28 English
4 Filing
Director's Dealing
2013-05-28 English
S-8 Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC by Insmed Incorporated. It relates to the registration of shares under employee benefit plans, specifically the 2013 Incentive Plan and stock option inducement awards. The document includes details about the securities to be registered, incorporation by reference of prior filings (10-K, 10-Q, 8-K), and exhibits related to corporate governance documents and legal opinions. Form S-8 is a registration statement used for securities issued to employees and is not a financial report, earnings release, or management discussion. It is a capital markets filing related to securities registration and issuance under employee plans. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement or certification, so it is not RPA or RNS. Confidence is high due to clear identification of Form S-8 and content focused on securities registration for employee plans.
2013-05-24 English
S-3 Filing
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a registration statement under the Securities Act of 1933 for Insmed Incorporated, describing the registration of securities (common stock, preferred stock, warrants, debt securities, etc.) to be sold up to $100 million. The document includes details about the securities, the plan of distribution, risk factors, and other information typical of a prospectus related to capital raising. This is not a financial report, earnings release, or management discussion, but a capital/financing update related to securities registration and offering. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed registration information, not just an announcement or notice, so it is not RPA or RNS. Confidence is high given the clear SEC form type and content.
2013-05-24 English
10-Q Filing
Interim / Quarterly Report Q1 2013
2013-05-07 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 7, 2013, reporting the issuance of a press release regarding financial results for the quarter ended March 31, 2013. The text explicitly states that the press release is being furnished as an exhibit and that the information is not deemed filed for certain regulatory purposes. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of financial results. The length is 3362 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a current report announcing financial results but does not contain the full earnings release or detailed financial data itself.
2013-05-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.